Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?

Am J Respir Crit Care Med. 2022 Jun 15;205(12):1379-1381. doi: 10.1164/rccm.202202-0301ED.

Authors

Christopher N Schmickl¹, Bradley A Edwards^{2

3}, Atul Malhotra¹

Affiliations

¹ Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego San Diego, California.
² School of Biomedical Sciences and Biomedical Discovery Institute.
³ Turner Institute for Brain and Mental Health Monash University Melbourne, Victoria, Australia.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Sleep Apnea Syndromes*
Sleep Apnea, Obstructive* / drug therapy
Sleep Apnea, Obstructive* / physiopathology
Thiazines* / therapeutic use

Substances

Thiazines
sulthiame

Grants and funding